Loading…

Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study

s A rapid, sensitive, and selective method for determining dihydroxymelphalan ( DHM ) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery...

Full description

Saved in:
Bibliographic Details
Published in:Journal of analytical chemistry (New York, N.Y.) N.Y.), 2014-04, Vol.69 (4), p.377-383
Main Authors: Sidorova, A. A., Grigoriev, A. V., Timofeeva, E. S., Levchenko, E. V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43
cites cdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43
container_end_page 383
container_issue 4
container_start_page 377
container_title Journal of analytical chemistry (New York, N.Y.)
container_volume 69
creator Sidorova, A. A.
Grigoriev, A. V.
Timofeeva, E. S.
Levchenko, E. V.
description s A rapid, sensitive, and selective method for determining dihydroxymelphalan ( DHM ) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.
doi_str_mv 10.1134/S1061934814040108
format article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A372884737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A372884737</galeid><sourcerecordid>A372884737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</originalsourceid><addsrcrecordid>eNp9kU1v1DAQQCMEEqXwA7hZ4oTUtJ44Hw63agu00iIQS8_RrD1JXRJ7ZTtSw6_Hq-1lxQrNYUYz781hJsveA78EEOXVBngNrSgllLzkwOWL7AxqLnMBbfsy1Wmc7-evszchPHLOWwn1WfbnhiL5yViMxlnmeqbNw6K9e1omGncPOKJlxrId-X4OGOmCbUfnNNuNGCa8YGg1G2c7sGhCmIltF3b7Y73Kv20-sftAexdZ2uMnVO63sRSNYiHOenmbvepxDPTuOZ9n918-_1rd5uvvX-9W1-tclUUTc8RCQkO8kb2WLddEVJPgVS8qRNAF1y1gCVrWmiq-bXSlBWxVDQ2QqlQpzrMPh70DjtQZ27voUU0mqO5aNIWUZSOaROUnqIEseRydpd6k9hF_eYJPoWky6qTw8UhITKSnOOAcQne3-XnMwoFV3oXgqe923kzolw54t_9398-_k1McnJBYO5DvHt3sbbrsf6S_z7erTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</title><source>Springer Link</source><creator>Sidorova, A. A. ; Grigoriev, A. V. ; Timofeeva, E. S. ; Levchenko, E. V.</creator><creatorcontrib>Sidorova, A. A. ; Grigoriev, A. V. ; Timofeeva, E. S. ; Levchenko, E. V.</creatorcontrib><description>s A rapid, sensitive, and selective method for determining dihydroxymelphalan ( DHM ) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.</description><identifier>ISSN: 1061-9348</identifier><identifier>EISSN: 1608-3199</identifier><identifier>DOI: 10.1134/S1061934814040108</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Analytical Chemistry ; Antimitotic agents ; Antineoplastic agents ; Chemical properties ; Chemistry ; Chemistry and Materials Science ; High performance liquid chromatography ; Mass spectrometry ; Pharmacokinetics ; Physiological aspects</subject><ispartof>Journal of analytical chemistry (New York, N.Y.), 2014-04, Vol.69 (4), p.377-383</ispartof><rights>Pleiades Publishing, Ltd. 2014</rights><rights>COPYRIGHT 2014 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</citedby><cites>FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Sidorova, A. A.</creatorcontrib><creatorcontrib>Grigoriev, A. V.</creatorcontrib><creatorcontrib>Timofeeva, E. S.</creatorcontrib><creatorcontrib>Levchenko, E. V.</creatorcontrib><title>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</title><title>Journal of analytical chemistry (New York, N.Y.)</title><addtitle>J Anal Chem</addtitle><description>s A rapid, sensitive, and selective method for determining dihydroxymelphalan ( DHM ) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.</description><subject>Analytical Chemistry</subject><subject>Antimitotic agents</subject><subject>Antineoplastic agents</subject><subject>Chemical properties</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>High performance liquid chromatography</subject><subject>Mass spectrometry</subject><subject>Pharmacokinetics</subject><subject>Physiological aspects</subject><issn>1061-9348</issn><issn>1608-3199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kU1v1DAQQCMEEqXwA7hZ4oTUtJ44Hw63agu00iIQS8_RrD1JXRJ7ZTtSw6_Hq-1lxQrNYUYz781hJsveA78EEOXVBngNrSgllLzkwOWL7AxqLnMBbfsy1Wmc7-evszchPHLOWwn1WfbnhiL5yViMxlnmeqbNw6K9e1omGncPOKJlxrId-X4OGOmCbUfnNNuNGCa8YGg1G2c7sGhCmIltF3b7Y73Kv20-sftAexdZ2uMnVO63sRSNYiHOenmbvepxDPTuOZ9n918-_1rd5uvvX-9W1-tclUUTc8RCQkO8kb2WLddEVJPgVS8qRNAF1y1gCVrWmiq-bXSlBWxVDQ2QqlQpzrMPh70DjtQZ27voUU0mqO5aNIWUZSOaROUnqIEseRydpd6k9hF_eYJPoWky6qTw8UhITKSnOOAcQne3-XnMwoFV3oXgqe923kzolw54t_9398-_k1McnJBYO5DvHt3sbbrsf6S_z7erTQ</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Sidorova, A. A.</creator><creator>Grigoriev, A. V.</creator><creator>Timofeeva, E. S.</creator><creator>Levchenko, E. V.</creator><general>Pleiades Publishing</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope></search><sort><creationdate>20140401</creationdate><title>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</title><author>Sidorova, A. A. ; Grigoriev, A. V. ; Timofeeva, E. S. ; Levchenko, E. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analytical Chemistry</topic><topic>Antimitotic agents</topic><topic>Antineoplastic agents</topic><topic>Chemical properties</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>High performance liquid chromatography</topic><topic>Mass spectrometry</topic><topic>Pharmacokinetics</topic><topic>Physiological aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sidorova, A. A.</creatorcontrib><creatorcontrib>Grigoriev, A. V.</creatorcontrib><creatorcontrib>Timofeeva, E. S.</creatorcontrib><creatorcontrib>Levchenko, E. V.</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Science</collection><jtitle>Journal of analytical chemistry (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sidorova, A. A.</au><au>Grigoriev, A. V.</au><au>Timofeeva, E. S.</au><au>Levchenko, E. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</atitle><jtitle>Journal of analytical chemistry (New York, N.Y.)</jtitle><stitle>J Anal Chem</stitle><date>2014-04-01</date><risdate>2014</risdate><volume>69</volume><issue>4</issue><spage>377</spage><epage>383</epage><pages>377-383</pages><issn>1061-9348</issn><eissn>1608-3199</eissn><abstract>s A rapid, sensitive, and selective method for determining dihydroxymelphalan ( DHM ) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S1061934814040108</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1061-9348
ispartof Journal of analytical chemistry (New York, N.Y.), 2014-04, Vol.69 (4), p.377-383
issn 1061-9348
1608-3199
language eng
recordid cdi_gale_infotracmisc_A372884737
source Springer Link
subjects Analytical Chemistry
Antimitotic agents
Antineoplastic agents
Chemical properties
Chemistry
Chemistry and Materials Science
High performance liquid chromatography
Mass spectrometry
Pharmacokinetics
Physiological aspects
title Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A42%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20dihydroxymelphalan%20in%20perfusate,%20blood%20plasma,%20and%20lung%20tissue%20by%20HPLC-MS:%20Use%20in%20a%20pharmacokinetic%20study&rft.jtitle=Journal%20of%20analytical%20chemistry%20(New%20York,%20N.Y.)&rft.au=Sidorova,%20A.%20A.&rft.date=2014-04-01&rft.volume=69&rft.issue=4&rft.spage=377&rft.epage=383&rft.pages=377-383&rft.issn=1061-9348&rft.eissn=1608-3199&rft_id=info:doi/10.1134/S1061934814040108&rft_dat=%3Cgale_cross%3EA372884737%3C/gale_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A372884737&rfr_iscdi=true